Daniel Poneman
Analyst · Lake Street Capital Markets. Please proceed with your question
Thank you, Dan, and thank you to everyone on the call today. As we have discussed in previous calls, the health and welfare of our employees and their families is our paramount concern. The pandemic has certainly forced us to change the way we do our work in order to protect our people. Fortunately, it has not taken away our ability to deliver on our customer orders and we expect to continue making those deliveries as planned in the months and years ahead. Indeed, Centrus is fortunate in that the COVID-19 pandemic does not affect our revenue in the way that it does for direct to consumer businesses. Nearly all of our revenue comes from stable, long-term contracts with utilities and the U.S. government. This was another exciting quarter for Centrus. We launched a public offering, raising about $25 million before expenses. We also announced a cash tender offer to purchase up to $60 million in Series B senior preferred stock. I can't go into much detail on that because the tender offer is still open, but we are optimistic about what the future holds. Our long-term order book in our low-enriched uranium or LEU segment remains at about $1 billion, which includes about $300 million in deferred revenue. In terms of financial results, Centrus reported $33.6 million in total revenue and a net loss of $7 million for the third quarter. That is a significant variation from last quarter, unfortunately, but those of you who regularly tune into these quarterly calls know, because you've heard me repeat it many times, that quarter-to-quarter variations are expected and reflect the timing of when we make deliveries. What matters is the annual performance, not what happens in any one quarter. That is why we are pleased that the long-term trend in the market remains positive. Spot prices for enrichment measured in dollars per separative work units, or SWU, have increased by almost 50% since bottoming out in August of 2018. As the price has continued to climb, more utilities have gone back into the market to secure their fuel supply for future years. So, we expect to have strong selling opportunities moving forward. Long-time listeners to our quarterly calls have also heard us discuss the Russian Suspension Agreement, a trade agreement between the United States and Russia that places limits on the amount of Russian nuclear fuel that can be imported. As many of you know, we faced a significant risk to our largest supply contract as the U.S. Department of Commerce worked to extend those import limits past the end of this year when they were scheduled to expire. I am pleased to report that this issue has now been resolved. While the import limits have been extended, the agreement signed between the two governments on October 5 expressly allocates a portion of the allowable imports to Centrus. While the exact quantities set aside for Centrus are confidential, we expect that they will give us what we need to achieve the goals of our strategic plan and to continue to serve our customers. This has removed a significant source of uncertainty in the market and helped to solidify an important source of revenue for us as we go forward. Turning to our Centrus technical solutions segment, our incredibly talented team continues making steady progress on the three-year $115 million contract we have in place with the U.S. Department of Energy. Under that contract, we are building a cascade of centrifuges that will demonstrate production of a next-generation nuclear fuel called High-Assay, Low-Enriched Uranium, or HALEU, as we call it. The standard low-enriched uranium fuel, or LEU, that powers our existing fleet of commercial reactors is enriched to a concentration of the physical isotope U-235 of a little less than 5%. HALEU is further enriched so that the U-235 concentration is between 5% and 20%. The higher concentration of U-235 in HALEU allows for smaller fuel cores, better fuel utilization, reduced volumes of waste and a variety of other advantages. There is growing interest in HALEU, both as an upgrade for existing reactors and to fuel a new generation of advanced reactors. The challenge is that HALEU is not commercially available today from Western suppliers, which makes it hard for U.S. advanced reactor developers to market their new designs to prospective customers. With the help of our contract with the U.S. Department of Energy, Centrus is working to solve that problem for the industry. We intend to be the first to market with commercial HALEU production under license by the U.S. Nuclear Regulatory Commission and we are well on our way. Construction activities are on track, on schedule and on budget. While we have experienced issues with some of our suppliers as a result of the pandemic, we have been able to remain on schedule and on budget for the project. Of course, we cannot rule out that possibility that the continued effects of COVID may change that in the future and as I said at the outset, protecting the health and safety of our employees is always our paramount concern. That said, we will continue to work with the U.S. Department of Energy to minimize any impact to the cost or schedule of the program as we move forward. The demonstration should be completed in early 2022, and we can then transition to commercial production. While the fuel requirements of advanced reactor designs vary quite a bit, the demonstration cascade will have enough capacity to support one to three small reactors, and we can expand in modular fashion as demand for HALEU grows. The facility in Piketon, Ohio is large enough to accommodate thousands of centrifuges, if necessary, enough to support a fleet of dozens or even hundreds of reactors if a robust market for advanced nuclear energy develops as part of our efforts to assure the resilience and security of the electric grid upon which we all depend for every facet of our lives as well as our intensifying efforts to combat climate change. In October, the Department of Energy announced the two winners of the Advanced Reactor Demonstration Program, or ARDP. We are proud to report that we have strong relations with both winners, TerraPower and X-energy. We have been working with X-energy since August 2017. And just two months ago, we announced a collaboration with TerraPower to work together to establish commercial scale, domestic production capabilities for HALEU to support their innovative new reactor. We also signed a Memorandum of Understanding with Terrestrial Energy to secure fuel supply for a future fleet of Integral Molten Salt Reactor power plants. Together, these announcements suggest a lot of exciting things that are coming for advanced reactors and the next-generation fuels needed to power them. And of course, we're continuing to work on developing other opportunities to promote advanced reactors generating carbon-free power for all. Centrus is uniquely positioned with the only deployment-ready U.S. enrichment technology that is suitable for national security missions. Under longstanding U.S. policy and binding nonproliferation treaties, the use of foreign origin uranium or foreign enrichment technologies for national security purposes is prohibited, which means that an American technology, like the one that we have developed, will ultimately be needed to meet America's long-term national security requirements for enriched uranium. Those requirements are currently met from the existing stockpile of highly-enriched uranium left over from the cold war, but the United States Department of Energy has said that a new domestic enrichment capability eventually will be required for missions like maintaining the tritium supplies needed to support our nuclear deterrent and fueling our nuclear Navy. Centrus stands ready to meet those requirements when the need arises. And now for more details on the quarterly financial results, I will turn the call over to Philip.